Market News AIOpen the app

MGRX stock news · Mangoceuticals, Inc.

Stories about Mangoceuticals, Inc. (MGRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MGRX

Follow Mangoceuticals, Inc. (MGRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MGRX
Free on the App Store and Google Play, or on the web.
  1. Nov 6, 2026, 5:45 PM ET · Market

    Mangoceuticals, Inc. announced the date for its 2025 and 2026 shareholder meeting and new stock details.

    Neutral

    Mangoceuticals approved terms for a proposed sale of up to 1,000,000 preferred shares at $10 each. The terms are not effective, so this filing does not yet change its outlook.

  2. Oct 1, 2026, 3:55 PM ET · Market

    Mangoceuticals, Inc. has signed an important deal to raise $1,750,000 from private investors.

    Neutral

    Mangoceuticals is selling 25% of its patent-owning unit and has received $1.75 million so far. The cash helps, but giving up part of the unit leaves benefits and costs.

  3. Aug 21, 2026, 5:49 PM ET · Market

    MANGOCEUTICALS, INC. announces the end of a significant definitive agreement (MGRX).

    Bad for MGRX

    Mangoceuticals, Inc. has filed a Form 8-K indicating the termination of a material definitive agreement, which raises concerns about the company's future business prospects and may lead to a negative reaction in the market.